The Role of Serum CK18, TIMP1, and MMP-9 Levels in Predicting R0 Resection in Patients with Gastric Cancer

Table 4

Relationships of biomarker averages with clinical T, clinical N, and, accordingly, with clinical stage.

		CK18	MMP-9	TIMP1
		Ave. ± SD	Ave. ± SD	Ave. ± SD
Clinical T	3	5.8 ± 6.0	1619.0 ± 2427.7	503.5 ± 453.3
	4	6.5 ± 8.0	1234.2 ± 2082.5	542.1 ± 471.7
		0.942	0.416	0.482
Clinical N	Available	9.8 ± 9.1	2587.2 ± 2879.9	765.8 ± 615.3
	N/A	3.6 ± 1.3	901.5 ± 1706.0	355.2 ± 202.2
		0.045	0.008	0.022
Clinical stage	2	3.6 ± 1.3	655.8 ± 1045.9	351.1 ± 204.3
	3	9.5 ± 8.9	2871.5 ± 3073.1	751.4 ± 602.3
		0.016	0.002	0.014